by
Gus Iversen, Editor in Chief | August 03, 2018
From the August 2018 issue of HealthCare Business News magazine
HCB News: Are you satisfied with the data you are generating for asset management?
PF: Several years ago, Biomedical Engineering started a project to develop an asset life cycle management system that enhanced our capabilities for evidence-based device assessment, life cycle management, data validation and data mining. The data repository integrates with the Center’s RTLS and passive RFID systems providing location content to the assets, reporting and visualization applications. In the near future the Center’s purchasing and financial systems will be provided life cycle information about the devices enabling enhanced replacement planning. The project is investigating the integration of natural language data mining tools to enhance and expand the user interfaces and search capabilities. These tools enable Biomedical Engineering to review, generate and distribute asset information to a variety of users, including technical users, clinical engineering users, administration and executive staff.
HCB News: Are you happy with the relationship you have with OEMs? How could it be improved?
PF: The relationship with the OEM’s is typically a smooth one. I would note, that it is Biomed’s responsibility to be clear on the expectations and deliverables. The OEM should be clear on how data or PM compliance is reported within the institution, as well as identifying the processes for downloading field service information reports.
HCB News: Do you feel that new standards or regulations are needed to ensure that biomeds and ISOs are safe service for patients at the same level as manufacturers?
PF: I believe it is the role of the internal hospital Biomed organizations to define the standards and expectation for service and support. All supporting organizations should be using Biomed policies and procedures to define service and PM standards. Service standards should be altered based only on evidence-based analysis of a specific institution’s experiences, as defined by Biomed organizations.
Back to HCB News
